Rtw Investments as of Sept. 30, 2022
Portfolio Holdings for Rtw Investments
Rtw Investments holds 86 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals (ALNY) | 7.8 | $337M | 1.7M | 200.16 | |
| Ptc Therapeutics I (PTCT) | 6.5 | $282M | 5.6M | 50.20 | |
| Rocket Pharmaceuticals (RCKT) | 5.8 | $252M | 16M | 15.96 | |
| Thermo Fisher Scientific (TMO) | 5.1 | $221M | 436k | 507.19 | |
| Immunocore Hldgs Ads (IMCR) | 4.8 | $209M | 4.5M | 46.94 | |
| Masimo Corporation (MASI) | 4.7 | $203M | 1.4M | 141.16 | |
| Prometheus Biosciences | 4.3 | $188M | 3.2M | 59.01 | |
| Argenx Se Sponsored Adr (ARGX) | 3.8 | $165M | 467k | 353.05 | |
| Penumbra (PEN) | 3.1 | $132M | 698k | 189.60 | |
| Mirati Therapeutics | 3.0 | $132M | 1.9M | 69.84 | |
| Establishment Labs Holdings Ord (ESTA) | 3.0 | $129M | 2.4M | 54.61 | |
| Cytokinetics Com New (CYTK) | 2.9 | $125M | 2.6M | 48.45 | |
| Illumina (ILMN) | 2.5 | $108M | 564k | 190.79 | |
| Relmada Therapeutics (RLMD) | 2.3 | $98M | 2.6M | 37.02 | |
| Ultragenyx Pharmaceutical (RARE) | 2.3 | $98M | 2.4M | 41.41 | |
| Natera (NTRA) | 2.2 | $97M | 2.2M | 43.82 | |
| Celldex Therapeutics Com New (CLDX) | 2.0 | $87M | 3.1M | 28.11 | |
| Avidity Biosciences Ord (RNA) | 1.9 | $84M | 5.2M | 16.33 | |
| Axsome Therapeutics (AXSM) | 1.9 | $84M | 1.9M | 44.62 | |
| Cutera | 1.9 | $81M | 1.8M | 45.60 | |
| Vericel (VCEL) | 1.7 | $72M | 3.1M | 23.20 | |
| Iveric Bio | 1.5 | $65M | 3.6M | 17.94 | |
| Axonics Modulation Technolog (AXNX) | 1.4 | $62M | 885k | 70.44 | |
| Adicet Bio (ACET) | 1.4 | $60M | 4.2M | 14.22 | |
| ACADIA Pharmaceuticals (ACAD) | 1.4 | $60M | 3.7M | 16.36 | |
| Ventyx Biosciences (VTYX) | 1.2 | $54M | 1.6M | 34.91 | |
| Pmv Pharmaceuticals (PMVP) | 1.2 | $52M | 4.4M | 11.90 | |
| Regenxbio Inc equity us cm (RGNX) | 1.1 | $49M | 1.8M | 26.43 | |
| Stoke Therapeutics (STOK) | 1.1 | $47M | 3.7M | 12.84 | |
| Cincor Pharma | 1.1 | $46M | 1.4M | 32.82 | |
| Globus Med Cl A (GMED) | 1.0 | $45M | 748k | 59.57 | |
| Milestone Pharmaceuticals (MIST) | 0.9 | $40M | 4.3M | 9.19 | |
| Guardant Health (GH) | 0.9 | $39M | 726k | 53.83 | |
| Protagonist Therapeutics (PTGX) | 0.8 | $35M | 4.2M | 8.43 | |
| Tarsus Pharmaceuticals (TARS) | 0.8 | $35M | 2.0M | 17.12 | |
| Fulcrum Therapeutics (FULC) | 0.7 | $32M | 4.0M | 8.09 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.7 | $30M | 1.3M | 23.26 | |
| Avadel Pharmaceuticals Sponsored Adr | 0.7 | $29M | 5.7M | 5.01 | |
| Gh Research Ordinary Shares (GHRS) | 0.6 | $25M | 2.2M | 11.62 | |
| C4 Therapeutics Com Stk (CCCC) | 0.6 | $25M | 2.8M | 8.77 | |
| 10x Genomics Cl A Com (TXG) | 0.4 | $18M | 640k | 28.48 | |
| 2seventy Bio Common Stock | 0.4 | $18M | 1.2M | 14.55 | |
| Tandem Diabetes Care Com New (TNDM) | 0.4 | $15M | 322k | 47.85 | |
| Apyx Medical Corporation (APYX) | 0.4 | $15M | 3.4M | 4.49 | |
| Outset Med | 0.3 | $15M | 910k | 15.93 | |
| Castle Biosciences (CSTL) | 0.3 | $14M | 517k | 26.08 | |
| Dermtech Ord ord (DMTKQ) | 0.3 | $12M | 3.1M | 3.96 | |
| Jounce Therapeutics | 0.3 | $12M | 5.1M | 2.34 | |
| Olink Hldg Ab Sponsored Ads (OLK) | 0.3 | $12M | 982k | 12.14 | |
| Third Harmonic Bio (THRD) | 0.3 | $12M | 610k | 18.97 | |
| Oyster Point Pharma | 0.3 | $12M | 2.0M | 5.62 | |
| Aadi Bioscience (WHWK) | 0.2 | $11M | 765k | 14.13 | |
| Allakos | 0.2 | $10M | 1.6M | 6.12 | |
| Monte Rosa Therapeutics (GLUE) | 0.2 | $9.9M | 1.2M | 8.17 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.2 | $9.9M | 1.0M | 9.90 | |
| Immunic (IMUX) | 0.2 | $8.7M | 2.8M | 3.16 | |
| Pulmonx Corp (LUNG) | 0.2 | $7.7M | 461k | 16.66 | |
| Renovacor | 0.2 | $7.6M | 3.0M | 2.52 | |
| Urogen Pharma (URGN) | 0.2 | $7.1M | 858k | 8.32 | |
| Tenaya Therapeutics (TNYA) | 0.2 | $7.1M | 2.5M | 2.90 | |
| Science 37 Holdings | 0.2 | $7.0M | 4.3M | 1.61 | |
| Research Alliance Corp Ii Com Cl A | 0.1 | $6.3M | 637k | 9.83 | |
| Bcls Acquisition Corp Com Cl A | 0.1 | $6.1M | 613k | 10.02 | |
| Brainsway Sponsored Ads (BWAY) | 0.1 | $5.8M | 1.6M | 3.61 | |
| Akoya Biosciences (AKYA) | 0.1 | $5.7M | 484k | 11.75 | |
| 908 Devices (MASS) | 0.1 | $5.1M | 312k | 16.45 | |
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.1 | $5.0M | 500k | 9.91 | |
| Summit Healthcre Acquistn Unit 06/03/2026 | 0.1 | $4.9M | 500k | 9.85 | |
| Arya Sciences Acquisitn Corp Class A Ord Shs | 0.1 | $4.9M | 500k | 9.80 | |
| Sight Sciences (SGHT) | 0.1 | $4.2M | 665k | 6.35 | |
| 5 01 Acquisition Corp Com Cl A | 0.1 | $3.9M | 392k | 10.00 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.1 | $3.9M | 500k | 7.76 | |
| Immatics SHS (IMTX) | 0.1 | $3.5M | 350k | 10.00 | |
| Tela Bio (TELA) | 0.1 | $3.3M | 390k | 8.52 | |
| Medicus Sciences Acquisition Cl A Shs | 0.1 | $3.0M | 300k | 9.90 | |
| Johnson & Johnson (JNJ) | 0.1 | $3.0M | 18k | 163.35 | |
| Exagen (XGN) | 0.1 | $2.8M | 1.0M | 2.71 | |
| Roivant Sciences SHS (ROIV) | 0.1 | $2.6M | 803k | 3.22 | |
| Landos Biopharma | 0.1 | $2.6M | 4.0M | 0.65 | |
| Essa Pharma Com New (EPIX) | 0.1 | $2.4M | 1.3M | 1.82 | |
| Nyxoah S A SHS (NYXH) | 0.1 | $2.2M | 345k | 6.30 | |
| Aslan Pharmaceuticals Ads | 0.0 | $1.8M | 3.0M | 0.60 | |
| Nautilus Biotechnology (NAUT) | 0.0 | $1.3M | 600k | 2.12 | |
| Miromatrix Med | 0.0 | $1.2M | 280k | 4.38 | |
| Renovacor *w Exp 99/99/999 | 0.0 | $28k | 350k | 0.08 | |
| Medicus Sciences Acquisition *w Exp 02/12/202 | 0.0 | $999.930000 | 33k | 0.03 |
